3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
22
Carcinoma, Non-Small-Cell Lung
15
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
11
Carcinoma, Hepatocellular
9
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Mycosis Fungoides
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Carcinoma, Renal Cell
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm Metastasis
4
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Colonic Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Sezary Syndrome
3
Rectal Neoplasms
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Interventions
Gemcitabine
15
Cisplatin
15
pembrolizumab
9
Oxaliplatin
7
durvalumab
5
Leucovorin
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
Platinum
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
Trastuzumab
3
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
zanidatamab
2
fludarabine
2
Paclitaxel
2
Nivolumab
2
Folfox protocol
2
Docetaxel
2
Cyclophosphamide
2
Biopsy
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
pertuzumab
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Disulfides
×
1 year
×
Clear all
No trials found.